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Abstract
Members	of	the	SLC36	family	of	proton-coupled	amino	acid	transporters	are	involved	in	membrane
transport	of	amino	acids	and	derivatives.	The	four	transporters	show	variable	tissue	expression
patterns	and	are	expressed	in	various	cell	types	at	the	plasma-membrane	and	in	intracellular
organelles.	PAT1	is	expressed	at	the	luminal	surface	of	the	small	intestine	and	absorbs	amino	acids
and	derivatives	[3].	In	lysosomes,	PAT1	functions	as	an	efflux	mechanism	for	amino	acids	produced
during	intralysosomal	proteolysis	[2,	18].	PAT2	is	expressed	at	the	apical	membrane	of	the	renal
proximal	tubule	[6]	and	at	the	plasma-membrane	in	brown/beige	adipocytes	[20].	PAT1	and	PAT4	are
involved	in	regulation	of	the	mTORC1	pathway	[11].	More	comprehensive	lists	of	substrates	can	be
found	within	the	reviews	under	Further	Reading	and	in	the	references	[3].
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This	is	a	citation	summary	for	SLC36	family	of	proton-coupled	amino	acid	transporters	in	the	Guide
to	Pharmacology	database	(GtoPdb).	It	exists	purely	as	an	adjunct	to	the	database	to	facilitate	the
recognition	of	citations	to	and	from	the	database	by	citation	analyzers.	Readers	will	almost	certainly
want	to	visit	the	relevant	sections	of	the	database	which	are	given	here	under	database	links.
GtoPdb	is	an	expert-driven	guide	to	pharmacological	targets	and	the	substances	that	act	on	them.
GtoPdb	is	a	reference	work	which	is	most	usefully	represented	as	an	on-line	database.	As	in	any
publication	this	work	should	be	appropriately	cited,	and	the	papers	it	cites	should	also	be	recognized.
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